Cargando…
Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
Background: Alzheimer’s disease (AD) is a debilitating neurodegenerative condition with few treatment options available. Drug repurposing studies have sought to identify existing drugs that could be repositioned to treat AD; however, the effectiveness of drug repurposing for AD remains unclear. This...
Autores principales: | Grabowska, Monika E., Huang, Annabelle, Wen, Zhexing, Li, Bingshan, Wei, Wei-Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512468/ https://www.ncbi.nlm.nih.gov/pubmed/37745051 http://dx.doi.org/10.3389/fphar.2023.1257700 |
Ejemplares similares
-
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023) -
Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022) -
Research trends and frontiers on antiphospholipid syndrome: A 10-year bibliometric analysis (2012–2021)
por: Wu, Teng, et al.
Publicado: (2022) -
Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023) -
On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)